Ray D. Page, DO, PhD, FACOI
- Weatherford, Texas
“There is nothing more important to me as a physician than your successful cancer treatment. I’ve been in practice for nearly two decades and have had the privilege of telling many patients that there is life beyond cancer. As President of The Center for Cancer and Blood Disorders, I want to lead by example, practicing a firm belief that all patients should receive the finest medical care available, with the same concern and compassion as a cherished member of the family.”
Dr. Page practices as a medical oncologist and hematologist at The Center for Cancer and Blood Disorders in Fort Worth and in Weatherford where he is a strong advocate for the highest quality of patient care. As President, he and his colleagues have created the most comprehensive community cancer care in the north Texas region, ensuring the patient’s journey includes integrated access to all components of the continuum of cancer care.
Dr. Page grew up in Grand Prairie, Texas and received his Bachelor of Science Degree in Chemistry and Biology from Southwestern University in 1984. He then received a Master’s Degree in Physiology at Baylor University Graduate School-Baylor College of Dentistry. He entered the nation’s first combined D.O. /Ph. D. medical scientist program at the University of North Texas Health Science Center (UNTHSC) in Fort Worth and in 1991 received his Ph.D. in Pharmacology along with his Doctorate in Osteopathic Medicine. Dr. Page completed his residency in internal medicine at the UNTHSC/Osteopathic Medical Center of Texas, and completed a combined oncology/hematology fellowship at the University of Texas M. D. Anderson Cancer Center.
Dr. Page has been actively engaged administratively in numerous cancer related roles. He currently serves as an ASCO representative to the American Medical Association House of Delegates. He is the Chair-Elect of ASCO’s Clinical Practice Committee. He also serves on ASCO’s Nominating Committee as the community oncology representative. Dr. Page also serves on ASCO’s Government Relations Committee. He was the previous Chair of ASCO’s State Affiliates Council and is currently the Texas Representative. Dr. Page serves on several working groups involving Payment Reform, Clinical Pathways, 340B, Site Neutrality, Provider/Payer relationships, Drug Shortages, Sunshine Law, and the Conquer Cancer Foundation Grant Review Committee.
He is the Immediate-past President of the Texas Society of Clinical Oncology and serves on the Legislative, Education and Membership Committees. Dr. Page is politically active both in Texas and nationally working on cancer related legislative issues. Dr. Page has served as a Consultant to the Texas Medical Association Cancer Committee, and the Texas Osteopathic Medical Association representative on the TMA Physician Oncology Education Program. He also serves as one of the two mentors of ASCO’s new Healthcare Policy Fellowship program.
Dr. Page has been instrumental in the development of a national oncology “Supergroup”, Quality Cancer Care Alliance (QCCA) where he serves on the board, executive committee, and chairs the membership committee. He serves on the Physician Advisory Boards of VitalSource GPO and Flatiron Health. Dr. Page is a member of the Via Oncology Pathways Steering Committee and Publications Committee and serves on the Lung cancer and Melanoma Advisory Panels. He was a member of the Weatherford Regional Medical Center Board of Directors and is currently the Vice-Chief of staff and member of the Medical Education Committee for the Internal Medicine residency program. He previously served on the Tarrant County American Cancer Society Board. Dr. Page is on the Fort Worth Adolescent Young Adult Cancer Task Force and Board. He also serves on the Board of the Careity Foundation.
As Director of Research, Dr. Page remains at the forefront of new drug development and anticancer therapies which enable patients to get novel cancer treatments closer to home. He has been the Principle Investigator of over 200 oncology clinical trials. He has a special interest in improving chemotherapy drug delivery resulting in better treatment responses and less toxicities and does collaborate research with Dr. Andreas Lacko at UNTHSC.
He has been married to Dr. Sheila Page for 29 years. They have 5 children and live in Aledo, Texas. Dr. Page is a member of St. Paul Lutheran Church and has been engaged in several roles including prior work with the Sudanese Refugee Ministry and starting a new mission church in Aledo. Dr. Page is on the President’s Council at Southwestern University, is the Class of 1984 Class Agent, and on the Advisory Panel for the Science Center. Dr. Page enjoys water sports, skiing, and fishing with his kids.
While at M. D. Anderson Cancer Center, he was appointed Junior Faculty Associate and also served as Chief Fellow. Dr. Page was the first osteopathic chief fellow at M.D. Anderson. Dr. Page has many publications and textbook chapters related to a wide variety of cancer-related subjects and basic science research which he has presented both nationally and internationally.
At the University of North Texas Health Science Center Dr. Page serves as an Adjunct Associate Professor in the Departments of Medicine and Biomedical Sciences where he actively participates in teaching and mentoring both the basic sciences and clinical medicine, and has received many academic honors and awards.
Dr. Page is one of four recipients of the Distinguished Alumnus Award from the UNTHSC, awarded in 2004. He was also honored with the Distinguished Alumnus Citation of Merit Award from Southwestern University in 2006. He was also named as the 2010 Distinguished Alumnus at Grand Prairie High School. He was named a “Healthcare Hero” by the Fort Worth Business Press, and for several years has been repeatedly named as a “Top Doctor” by Fort Worth Magazine and a “Texas Super Doctor” by Texas Monthly Magazine. Dr. Page was recently name to the “Texas Super Doctor Hall of Fame” in recognition of being named a “Super Doctor” by Texas Monthly magazine for every year since the program’s inception.